CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zeria Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zeria Pharmaceutical Co Ltd
10-11, Nihombashi Kobuna-cho
Phone: +81 336632351p:+81 336632351 CHUO-KU, TKY  103-8351  Japan Ticker: 45594559
Business Summary
Zeria Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the development of ethical drug business, consumer healthcare business and other business. The Company operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations
6411 Insurance agents, brokers, and service
6531 Real estate agents and managers

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Representative Director SachiakiIbe 82 6/27/2014 3/1/1972
President, Chief Operating Officer, Representative Director MitsuhiroIbe 51 6/27/2014 6/29/2010
Executive Officer, Chief Director of Finance and Accounting, Director of Finance, Director of Accou YasuhisaTanaka 4/1/2024 4/1/2024
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Tillotts Pharma AG Baslerstrasse 15 Rheinfelden Switzerland

Business Names
Business Name
4559
lona International Inc.
Tillotts Pharma AG
Zeria Pharmaceutical Co., Ltd.
ZERIA PHARMCEUTICAL CO., LTD.
ZPD A/S

General Information
Number of Employees: 1,729 (As of 3/31/2023)
Outstanding Shares: 44,079,936 (As of 12/31/2023)
Shareholders: 10,971
Stock Exchange: TYO
Fax Number: +81 336632352


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024